# Daniela Pugliese

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniela-pugliese/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,771 |
| Field | Inflammatory Bowel Disease |
| h-index | 36 |
| i10-index | 89 |
| Last Known Institution | Università Cattolica del Sacro Cuore |
| OpenAlex ID | https://openalex.org/A5073776627 |
| ORCID iD | 0000-0001-7930-5402 |
| Works | 333 |

## Researcher papers

- [Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study](https://scholariq.org/papers/long-term-safety-of-in-utero-exposure-to-anti-tnf-drugs-for-the-treatment-of/)
- [Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future](https://scholariq.org/papers/anti-tnf-therapy-for-ulcerative-colitis-current-status-and-prospects-for-the/)
- [Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study](https://scholariq.org/papers/paradoxical-psoriasis-in-a-large-cohort-of-patients-with-inflammatory-bowel/)
- [Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study](https://scholariq.org/papers/prevention-of-postoperative-recurrence-with-azathioprine-or-infliximab-in/)
- [Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants](https://scholariq.org/papers/immune-response-to-influenza-a-h1n1-vaccine-in-inflammatory-bowel-disease/)
- [Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year](https://scholariq.org/papers/faecal-calprotectin-assay-after-induction-with-anti-tumour-necrosis-factor/)
- [Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease](https://scholariq.org/papers/dual-targeted-therapy-a-possible-option-for-the-management-of-refractory/)
- [Diet and Nutrients in Gastrointestinal Chronic Diseases](https://scholariq.org/papers/diet-and-nutrients-in-gastrointestinal-chronic-diseases/)
- [Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases](https://scholariq.org/papers/novel-insights-into-the-pathogenesis-of-inflammatory-bowel-diseases/)
- [Adalimumab in active ulcerative colitis: A “real-life” observational study](https://scholariq.org/papers/adalimumab-in-active-ulcerative-colitis-a-real-life-observational-study/)
- [The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn’s Disease in Italy: An IG-IBD Survey](https://scholariq.org/papers/the-epidemiology-and-clinical-management-of-short-bowel-syndrome-and-chronic/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Università Cattolica del Sacro Cuore](https://scholariq.org/institutions/universita-cattolica-del-sacro-cuore/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.